{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:34:12Z","timestamp":1788564852572,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072707"],"award-info":[{"award-number":["82072707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Basic research project of Naval Medical University","award":["2023MS023"],"award-info":[{"award-number":["2023MS023"]}]},{"name":"Changhai Hospital Discipline Construction Fund","award":["2019YXK019"],"award-info":[{"award-number":["2019YXK019"]}]},{"name":"Changhai Hospital 234 Project and Basic Medicine Research Fund","award":["2023PY29"],"award-info":[{"award-number":["2023PY29"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04326-x","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:20:47Z","timestamp":1773746447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCL8-dependent recruitment of natural killer cells enhances the antitumor activity of neoadjuvant chemotherapy in gastric cancer"],"prefix":"10.1007","volume":"75","author":[{"given":"Yujie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"4326_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00052-2","author":"R Sundar","year":"2025","unstructured":"Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, Smyth EC (2025) Gastric cancer. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(25)00052-2","journal-title":"Lancet"},{"issue":"1","key":"4326_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19965-6","volume":"11","author":"BK Sah","year":"2020","unstructured":"Sah BK, Zhang B, Zhang H, Li J, Yuan F, Ma T, Shi M, Xu W, Zhu Z, Liu W et al (2020) Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer. Nat Commun 11(1):6093","journal-title":"Nat Commun"},{"issue":"1","key":"4326_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2024","unstructured":"Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, Qu XJ, Qiu H, Zhang YJ, Ying JE et al (2024) The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (London, England) 44(1):127\u2013172","journal-title":"Cancer Commun (London, England)"},{"issue":"2","key":"4326_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1245\/s10434-018-7063-8","volume":"26","author":"Y Nakamura","year":"2019","unstructured":"Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, Misawa K, Hirao M, Yoshida K, Oki E et al (2019) Survival outcomes of two phase 2 studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin for patients with gastric cancer after D2 gastrectomy. Ann Surg Oncol 26(2):465\u2013472","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"4326_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01549-z","volume":"38","author":"A Serizawa","year":"2021","unstructured":"Serizawa A, Kuramochi H, Taniguchi K, Ota M, Katagiri S, Yamada T, Kotake S, Ito S, Suzuki K, Yamamoto M (2021) Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer clinical T4 or N2-3. Med Oncol 38(9):98","journal-title":"Med Oncol"},{"issue":"16","key":"4326_CR6","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1002\/cam4.3224","volume":"9","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Lian C, Huo Z, Li M, Liu Y, Fan L, Tan B, Zhao X, Zhang Z, Wang D et al (2020) The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: a multicenter randomized clinical trial. Cancer Med 9(16):5731\u20135745","journal-title":"Cancer Med"},{"issue":"4","key":"4326_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10120-017-0781-y","volume":"21","author":"K Eto","year":"2018","unstructured":"Eto K, Hiki N, Kumagai K, Shoji Y, Tsuda Y, Kano Y, Yasufuku I, Okumura Y, Tsujiura M, Ida S et al (2018) Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications. Gastric Cancer 21(4):703\u2013709","journal-title":"Gastric Cancer"},{"issue":"3","key":"4326_CR8","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. CA Cancer J Clin 71(3):264\u2013279","journal-title":"CA Cancer J Clin"},{"key":"4326_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijsu.2018.01.008","volume":"51","author":"F Coccolini","year":"2018","unstructured":"Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, Fugazzola P, Tomasoni M, Glehen O, Catena F et al (2018) Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg (London, England) 51:120\u2013127","journal-title":"Int J Surg (London, England)"},{"issue":"6","key":"4326_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30321-2","volume":"18","author":"M Das","year":"2017","unstructured":"Das M (2017) Neoadjuvant chemotherapy: survival benefit in gastric cancer. Lancet Oncol 18(6):e307","journal-title":"Lancet Oncol"},{"issue":"12","key":"4326_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","volume":"17","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Humeau J, Buqu\u00e9 A, Zitvogel L, Kroemer G (2020) Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nat Rev Clin Oncol 17(12):725\u2013741","journal-title":"Nat Rev Clin Oncol"},{"issue":"22","key":"4326_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K (2022) Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci 9(22):e2201734","journal-title":"Adv Sci"},{"key":"4326_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003984","author":"X Xing","year":"2022","unstructured":"Xing X, Shi J, Jia Y, Dou Y, Li Z, Dong B, Guo T, Cheng X, Li X, Du H et al (2022) Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003984","journal-title":"J Immunother Cancer"},{"issue":"12","key":"4326_CR14","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.7150\/jca.31755","volume":"10","author":"Y Yu","year":"2019","unstructured":"Yu Y, Ma X, Zhang Y, Zhang Y, Ying J, Zhang W, Zhong Q, Zhou A, Zeng Y (2019) Changes in expression of multiple checkpoint molecules and infiltration of tumor immune cells after neoadjuvant chemotherapy in gastric cancer. J Cancer 10(12):2754\u20132763","journal-title":"J Cancer"},{"issue":"8","key":"4326_CR15","first-page":"4685","volume":"7","author":"M Hu","year":"2014","unstructured":"Hu M, Li K, Maskey N, Xu Z, Peng C, Wang B, Li Y, Yang G (2014) Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer. Int J Clin Exp Pathol 7(8):4685\u20134694","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4326_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1921443","volume":"10","author":"M Christina Svensson","year":"2021","unstructured":"Christina Svensson M, Lind\u00e9n A, Nygaard J, Borg D, Hedner C, Nodin B, Leandersson K, Jirstr\u00f6m K (2021) T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival. Oncoimmunology 10(1):1921443","journal-title":"Oncoimmunology"},{"key":"4326_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836389","volume":"12","author":"M Ma","year":"2022","unstructured":"Ma M, Sun J, Liu Z, Ouyang S, Zhang Z, Zeng Z, Li J, Kang W (2022) The immune microenvironment in gastric cancer: prognostic prediction. Front Oncol 12:836389","journal-title":"Front Oncol"},{"issue":"18","key":"4326_CR18","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79(18):4557\u20134566","journal-title":"Cancer Res"},{"issue":"1","key":"4326_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2574859","volume":"14","author":"F Baenke","year":"2025","unstructured":"Baenke F, Stammberger A, Sommer U, Br\u00fcckmann S, Merboth F, Polster H, Digomann D, Natusch Bufe L, Rupp L, Aust DE et al (2025) Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma. Oncoimmunology 14(1):2574859","journal-title":"Oncoimmunology"},{"issue":"1","key":"4326_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00262-021-02960-1","volume":"71","author":"IV Zurlo","year":"2022","unstructured":"Zurlo IV, Schino M, Strippoli A, Calegari MA, Cocomazzi A, Cassano A, Pozzo C, Di Salvatore M, Ricci R, Barone C et al (2022) Predictive value of NLR, TILs (CD4+\/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Cancer Immunol Immunother 71(1):45\u201355","journal-title":"Cancer Immunol Immunother"},{"key":"4326_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drup.2016.07.001","volume":"28","author":"RH Wijdeven","year":"2016","unstructured":"Wijdeven RH, Pang B, Assaraf YG, Neefjes J (2016) Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics. Drug Resist Updat 28:65\u201381","journal-title":"Drug Resist Updat"},{"key":"4326_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223672","author":"N Roussot","year":"2022","unstructured":"Roussot N, Ghiringhelli F, R\u00e9b\u00e9 C (2022) Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment. Cells. https:\/\/doi.org\/10.3390\/cells11223672","journal-title":"Cells"},{"issue":"1","key":"4326_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","volume":"7","author":"Q Gao","year":"2019","unstructured":"Gao Q, Wang S, Chen X, Cheng S, Zhang Z, Li F, Huang L, Yang Y, Zhou B, Yue D et al (2019) Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer 7(1):42","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4326_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17(2):97\u2013111","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4326_CR25","first-page":"129","volume":"16","author":"Y Sun","year":"2021","unstructured":"Sun Y, Feng X, Wan C, Lovell JF, Jin H, Ding J (2021) Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy. Asian J Pharm Sci 16(2):129\u2013132","journal-title":"Asian J Pharm Sci"},{"issue":"6","key":"4326_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610\u2013621","journal-title":"N Engl J Med"},{"issue":"1","key":"4326_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel TR, Lill JK, Altenburger LM (2024) How chemokines organize the tumour microenvironment. Nat Rev Cancer 24(1):28\u201350","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4326_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA (2008) Human natural killer cells. Blood 112(3):461\u2013469","journal-title":"Blood"},{"issue":"1","key":"4326_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00431-0","volume":"12","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhou W, Yang J, Yang J, Wang W (2023) Chimeric antigen receptor engineered natural killer cells for cancer therapy. Exp Hematol Oncol 12(1):70","journal-title":"Exp Hematol Oncol"},{"key":"4326_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164129","author":"N Du","year":"2021","unstructured":"Du N, Guo F, Wang Y, Cui J (2021) NK cell therapy: a rising star in cancer treatment. Cancers. https:\/\/doi.org\/10.3390\/cancers13164129","journal-title":"Cancers"},{"issue":"8","key":"4326_CR31","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/cas.14521","volume":"111","author":"Y Oya","year":"2020","unstructured":"Oya Y, Hayakawa Y, Koike K (2020) Tumor microenvironment in gastric cancers. Cancer Sci 111(8):2696\u20132707","journal-title":"Cancer Sci"},{"issue":"3","key":"4326_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/CJI.0b013e31824b3a76","volume":"35","author":"H Khallouf","year":"2012","unstructured":"Khallouf H, M\u00e4rten A, Serba S, Teichgr\u00e4ber V, B\u00fcchler MW, J\u00e4ger D, Schmidt J (2012) 5-fluorouracil and interferon-\u03b1 immunochemotherapy enhances immunogenicity of murine pancreatic cancer through upregulation of NKG2D ligands and MHC class I. J Immunother 35(3):245\u2013253","journal-title":"J Immunother"},{"issue":"2","key":"4326_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/CAD.0000000000001248","volume":"33","author":"M Xin","year":"2022","unstructured":"Xin M, Lin D, Yan N, Li H, Li J, Huang Z (2022) Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model. Anticancer Drugs 33(2):117\u2013123","journal-title":"Anticancer Drugs"},{"issue":"8","key":"4326_CR34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","volume":"21","author":"T Bald","year":"2020","unstructured":"Bald T, Krummel MF, Smyth MJ, Barry KC (2020) The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. Nat Immunol 21(8):835\u2013847","journal-title":"Nat Immunol"},{"issue":"5","key":"4326_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O (2012) The chemokine superfamily revisited. Immunity 36(5):705\u2013716","journal-title":"Immunity"},{"issue":"2","key":"4326_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2011.04.024","volume":"308","author":"K Hiwatashi","year":"2011","unstructured":"Hiwatashi K, Tamiya T, Hasegawa E, Fukaya T, Hashimoto M, Kakoi K, Kashiwagi I, Kimura A, Inoue N, Morita R et al (2011) Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2\/CCL8 induction. Cancer Lett 308(2):172\u2013180","journal-title":"Cancer Lett"},{"issue":"3","key":"4326_CR37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/eji.200838660","volume":"39","author":"S Struyf","year":"2009","unstructured":"Struyf S, Proost P, Vandercappellen J, Dempe S, Noyens B, Nelissen S, Gouwy M, Locati M, Opdenakker G, Dinsart C et al (2009) Synergistic up-regulation of MCP-2\/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects. Eur J Immunol 39(3):843\u2013857","journal-title":"Eur J Immunol"},{"issue":"2","key":"4326_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong T, Liu L, Jiang W, Zhou R (2020) DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol 20(2):95\u2013112","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"4326_CR39","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.4049\/jimmunol.181.10.7341","volume":"181","author":"C Hintzen","year":"2008","unstructured":"Hintzen C, Haan C, Tuckermann JP, Heinrich PC, Hermanns HM (2008) Oncostatin M-induced and constitutive activation of the JAK2\/STAT5\/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. J Immunol 181(10):7341\u20137349","journal-title":"J Immunol"},{"issue":"12","key":"4326_CR40","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG (2020) Targeting immunogenic cell death in cancer. Mol Oncol 14(12):2994\u20133006","journal-title":"Mol Oncol"},{"key":"4326_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879452","volume":"13","author":"WK Bae","year":"2022","unstructured":"Bae WK, Lee BC, Kim HJ, Lee JJ, Chung IJ, Cho SB, Koh YS (2022) A phase I study of locoregional high-dose autologous natural killer cell therapy with hepatic arterial infusion chemotherapy in patients with locally advanced hepatocellular carcinoma. Front Immunol 13:879452","journal-title":"Front Immunol"},{"issue":"9","key":"4326_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1866","volume":"6","author":"BI Bagus","year":"2023","unstructured":"Bagus BI (2023) Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: three years follow-up of resectable case. Cancer reports (Hoboken, NJ) 6(9):e1866","journal-title":"Cancer reports (Hoboken, NJ)"},{"key":"4326_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X241254743","volume":"12","author":"Y Yue","year":"2024","unstructured":"Yue Y, Zi M, Feng J, Wang W, Ren Z, Wu C, Yang Z (2024) Efficacy of nature killer cell combination chemotherapy for post-radical gastric cancer metastases: case report. SAGE Open Med Case Rep 12:2050313x241254743","journal-title":"SAGE Open Med Case Rep"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04326-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:04:29Z","timestamp":1773792269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04326-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04326-x","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest associated with this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research protocol was approved by the Research Ethics Committee of Changhai Hospital (Committee on Ethics of Medicine, Navy Medical University, PLA, No.82072707).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"112"}}